Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Neuroendocrine cancer of the prostate metastatic
ADR ID BADD_A10508
ADR Hierarchy
05      Endocrine disorders
05.08      Neoplastic and ectopic endocrinopathies
05.08.01      Endocrine neoplasms NEC
05.08.01.019      Neuroendocrine cancer of the prostate metastatic
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.25      Reproductive neoplasms male malignant and unspecified
16.25.01      Prostatic neoplasms malignant
16.25.01.008      Neuroendocrine cancer of the prostate metastatic
21      Reproductive system and breast disorders
21.04      Prostatic disorders (excl infections and inflammations)
21.04.02      Prostatic neoplasms and hypertrophy
21.04.02.012      Neuroendocrine cancer of the prostate metastatic
Description Not Available
MedDRA Code 10087499
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Neuroendocrine cancer of the prostate metastatic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone0.000334%
The 1th Page    1    Total 1 Pages